Scope Fluidics SA
WSE:SCP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jaeren Sparebank
OSE:JAREN
|
NO |
We don't have any information about SCP's insider trading.
Scope Fluidics SA
Glance View
Scope Fluidics SA engages in the research and development in the field of healthcare. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 30 full-time employees. The company went IPO on 2017-08-16. The firm focuses on diagnostic and med-tech solutions. The company develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The firm provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
